Format
Sort by

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 1052

1.
2.

Oral antidiabetic agents: current role in type 2 diabetes mellitus.

Krentz AJ, Bailey CJ.

Drugs. 2005;65(3):385-411. Review.

PMID:
15669880
3.

Bodyweight changes associated with antihyperglycaemic agents in type 2 diabetes mellitus.

Hermansen K, Mortensen LS.

Drug Saf. 2007;30(12):1127-42. Review.

PMID:
18035865
4.

The use of insulin secretagogues in the treatment of type 2 diabetes.

Luna B, Hughes AT, Feinglos MN.

Prim Care. 1999 Dec;26(4):895-915. Review.

PMID:
10523467
5.

Diabetes medications and body weight.

Mitri J, Hamdy O.

Expert Opin Drug Saf. 2009 Sep;8(5):573-84. doi: 10.1517/14740330903081725. Review.

PMID:
19538102
6.

Glycaemic effects of incretins in Type 1 diabetes mellitus: a concise review, with emphasis on studies in humans.

Dupre J.

Regul Pept. 2005 Jun 15;128(2):149-57. Review. Erratum in: Regul Pept. 2006 Mar 15;134(1):67-8.

PMID:
15780434
7.

A review of the effects of antihyperglycaemic agents on body weight: the potential of incretin targeted therapies.

Barnett A, Allsworth J, Jameson K, Mann R.

Curr Med Res Opin. 2007 Jul;23(7):1493-507. Review.

PMID:
17559747
8.

Novel peptides under development for the treatment of type 1 and type 2 diabetes mellitus.

Baron AD, Kim D, Weyer C.

Curr Drug Targets Immune Endocr Metabol Disord. 2002 Apr;2(1):63-82. Review.

PMID:
12477297
9.

New treatments for patients with type 2 diabetes mellitus.

Wolffenbuttel BH, Graal MB.

Postgrad Med J. 1996 Nov;72(853):657-62. Review.

10.

Harnessing the therapeutic potential of glucagon-like peptide-1: a critical review.

Baggio LL, Drucker DJ.

Treat Endocrinol. 2002;1(2):117-25. Review.

PMID:
15765627
11.

Promising new approaches.

Reasner CA 2nd.

Diabetes Obes Metab. 1999 May;1 Suppl 1:S41-8. Review.

PMID:
11220287
12.

Oral antidiabetic therapy in patients with heart disease. A cardiologic standpoint.

Fisman EZ, Tenenbaum A, Motro M, Adler Y.

Herz. 2004 May;29(3):290-8. Review.

PMID:
15167955
13.

Novel pharmacologic agents for type 2 diabetes.

Uwaifo GI, Ratner RE.

Endocrinol Metab Clin North Am. 2005 Mar;34(1):155-97. Review.

PMID:
15752927
14.

Importance of glucose control.

Edelman SV.

Med Clin North Am. 1998 Jul;82(4):665-87. Review.

PMID:
9706116
15.
16.

[Drug treatment of type 2 diabetes].

Tielmans A, Laloi-Michelin M, Coupaye M, Virally M, Meas T, Guillausseau PJ.

Presse Med. 2007 Feb;36(2 Pt 2):269-78. Review. French.

PMID:
17258675
17.

Oral antidiabetic agents in type 2 diabetes.

Levetan C.

Curr Med Res Opin. 2007 Apr;23(4):945-52. Review.

PMID:
17407651
18.

Diabetes beyond insulin: review of new drugs for treatment of diabetes mellitus.

Modi P.

Curr Drug Discov Technol. 2007 Jun;4(1):39-47. Review.

PMID:
17630927
19.

Type 2 diabetes and oral antihyperglycemic drugs.

Mizuno CS, Chittiboyina AG, Kurtz TW, Pershadsingh HA, Avery MA.

Curr Med Chem. 2008;15(1):61-74. Review.

PMID:
18220763
20.

New approaches to treating type 2 diabetes mellitus in the elderly: role of incretin therapies.

Abbatecola AM, Maggi S, Paolisso G.

Drugs Aging. 2008;25(11):913-25. doi: 10.2165/0002512-200825110-00002. Review.

PMID:
18947259
Items per page

Supplemental Content

Support Center